» Articles » PMID: 34284952

Non-coding RNAs in Cardiac Regeneration: Mechanism of Action and Therapeutic Potential

Overview
Date 2021 Jul 21
PMID 34284952
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

In the past two decades, thousands of non-coding RNAs (ncRNAs) have been discovered, annotated, and characterized in nearly every tissue under both physiological and pathological conditions. Here, we will focus on the role of ncRNAs, including microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs) in ischemic heart disease (IHD), which remains the leading cause of morbidity and mortality in humans-resulting in 8.9 million deaths annually. Cardiomyocyte (CM) proliferation, differentiation, and survival in addition to neovascularization of injured tissues and the prevention of fibrosis are commonly regarded as critically important for the recovery of the heart following myocardial infarction (MI). An abundance of evidence has been accumulated to show ncRNAs participate in cardiac recovery after MI. Because miRNAs are important regulators of cardiac regeneration, the therapeutic potential of at least five of these molecules has been assessed in large animal models of human IHD. In particular, miRNA-based interventions based on miR-132 and miR-92a inhibition in related diseases have displayed favorable outcomes that have provided the impetus for miRNA-based clinical trials for IHD. At the same time, the functional roles of lncRNAs and circRNAs in cardiac regeneration are also being explored. In the present review, we will summarize the latest ncRNA studies aimed at reversing damage to the ischemic heart and discuss the therapeutic potential of targeting miRNAs, lncRNAs, and circRNAs to stimulate cardiac regeneration.

Citing Articles

miR-1233-3p Inhibits Angiopoietin-1-Induced Endothelial Cell Survival, Migration, and Differentiation.

Sanchez V, Harel S, Saub A, Mayaki D, Hussain S Cells. 2025; 14(2).

PMID: 39851503 PMC: 11763389. DOI: 10.3390/cells14020075.


In-depth analysis of lupeol: delving into the diverse pharmacological profile.

Dalimunthe A, Carensia Gunawan M, Dhiya Utari Z, Dinata M, Halim P, Estherina S Pakpahan N Front Pharmacol. 2024; 15:1461478.

PMID: 39605919 PMC: 11598436. DOI: 10.3389/fphar.2024.1461478.


Circular RNA IGF1R Promotes Cardiac Repair via Activating β-Catenin Signaling by Interacting with DDX5 in Mice after Ischemic Insults.

Shan T, Yang T, Jing P, Bao Y, Zhou L, Zhu T Research (Wash D C). 2024; 7:0451.

PMID: 39193132 PMC: 11347128. DOI: 10.34133/research.0451.


Therapeutic Inhibition of Protects Against Cardiac Hypertrophy.

Wang Y, Zhang M, Wang R, Lin J, Ma Q, Guo H Circ Res. 2024; 135(3):434-449.

PMID: 38864216 PMC: 11257812. DOI: 10.1161/CIRCRESAHA.123.323356.


Overexpression of zinc-finger protein 418 inhibits pathological cardiac remodelling after acute myocardial infarction.

Jiang H, Lai F, Wang X, Meng F, Zhu W, Huang S ESC Heart Fail. 2024; 11(5):2869-2880.

PMID: 38714309 PMC: 11424367. DOI: 10.1002/ehf2.14823.


References
1.
Nishi H, Ono K, Iwanaga Y, Horie T, Nagao K, Takemura G . MicroRNA-15b modulates cellular ATP levels and degenerates mitochondria via Arl2 in neonatal rat cardiac myocytes. J Biol Chem. 2009; 285(7):4920-30. PMC: 2836096. DOI: 10.1074/jbc.M109.082610. View

2.
Orom U, Nielsen F, Lund A . MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation. Mol Cell. 2008; 30(4):460-71. DOI: 10.1016/j.molcel.2008.05.001. View

3.
Heallen T, Morikawa Y, Leach J, Tao G, Willerson J, Johnson R . Hippo signaling impedes adult heart regeneration. Development. 2013; 140(23):4683-90. PMC: 3833428. DOI: 10.1242/dev.102798. View

4.
Yan L, Yang M, Guo H, Yang L, Wu J, Li R . Single-cell RNA-Seq profiling of human preimplantation embryos and embryonic stem cells. Nat Struct Mol Biol. 2013; 20(9):1131-9. DOI: 10.1038/nsmb.2660. View

5.
Li X, He X, Wang H, Li M, Huang S, Chen G . Loss of AZIN2 splice variant facilitates endogenous cardiac regeneration. Cardiovasc Res. 2018; 114(12):1642-1655. PMC: 6148334. DOI: 10.1093/cvr/cvy075. View